인간 메타뉴모바이러스 백신

본 개시내용은 항원성 융합전 hMPV F 폴리펩티드, 융합전 hMPV F 폴리펩티드를 인코딩하는 핵산 서열(예를 들어, RNA 서열, 예를 들어, mRNA 서열), 항원성 융합전 hMPV F 폴리펩티드를 포함하는 조성물, 융합전 hMPV F 폴리펩티드를 인코딩하는 핵산 서열을 포함하는 조성물, 및 hMPV 백신을 제공한다. The present disclosure provides antigenic prefusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences,...

Full description

Saved in:
Bibliographic Details
Main Authors DINAPOLI JOSH, DANZ HILLARY, CHIVUKULA SUDHA, MUNDLE SOPHIA, KISHKO MICHAEL, ZHANG LINONG, ANOSOVA NATALIE, SASMAL SUKANYA, GROPPO RACHEL, STRUGNELL TOD, CHAN YVONNE, ALAMARES SAPUAY JUDITH, STUEBLER ANTONIA
Format Patent
LanguageKorean
Published 05.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:본 개시내용은 항원성 융합전 hMPV F 폴리펩티드, 융합전 hMPV F 폴리펩티드를 인코딩하는 핵산 서열(예를 들어, RNA 서열, 예를 들어, mRNA 서열), 항원성 융합전 hMPV F 폴리펩티드를 포함하는 조성물, 융합전 hMPV F 폴리펩티드를 인코딩하는 핵산 서열을 포함하는 조성물, 및 hMPV 백신을 제공한다. The present disclosure provides antigenic prefusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding prefusion hMPV F polypeptides, compositions comprising antigenic prefusion hMPV F polypeptides, compositions comprising nucleic acid sequences encoding prefusion hMPV F polypeptides, and hMPV vaccines.
Bibliography:Application Number: KR20247021492